158 related articles for article (PubMed ID: 35058135)
1. Risk factors for hepatic encephalopathy and mortality in cirrhosis: The role of cognitive impairment, muscle alterations and shunts.
Nardelli S; Riggio O; Gioia S; Merli M; Spagnoli A; di Martino M; Pelle G; Ridola L
Dig Liver Dis; 2022 Aug; 54(8):1060-1065. PubMed ID: 35058135
[TBL] [Abstract][Full Text] [Related]
2. Muscle Alterations Are Associated With Minimal and Overt Hepatic Encephalopathy in Patients With Liver Cirrhosis.
Nardelli S; Lattanzi B; Merli M; Farcomeni A; Gioia S; Ridola L; Riggio O
Hepatology; 2019 Nov; 70(5):1704-1713. PubMed ID: 31038758
[TBL] [Abstract][Full Text] [Related]
3. Risk of falls in patients with cirrhosis evaluated by timed up and go test: Does muscle or brain matter more?
Nardelli S; Gioia S; Ridola L; Carlin M; Cioffi AD; Merli M; Spagnoli A; Riggio O
Dig Liver Dis; 2022 Mar; 54(3):371-377. PubMed ID: 34233863
[TBL] [Abstract][Full Text] [Related]
4. Sarcopenia and cognitive impairment in liver cirrhosis: A viewpoint on the clinical impact of minimal hepatic encephalopathy.
Nardelli S; Gioia S; Faccioli J; Riggio O; Ridola L
World J Gastroenterol; 2019 Sep; 25(35):5257-5265. PubMed ID: 31558871
[TBL] [Abstract][Full Text] [Related]
5. The modification of quantity and quality of muscle mass improves the cognitive impairment after TIPS.
Gioia S; Merli M; Nardelli S; Lattanzi B; Pitocchi F; Ridola L; Riggio O
Liver Int; 2019 May; 39(5):871-877. PubMed ID: 30667572
[TBL] [Abstract][Full Text] [Related]
6. Minimal hepatic encephalopathy and critical flicker frequency are associated with survival of patients with cirrhosis.
Ampuero J; Simón M; Montoliú C; Jover R; Serra MÁ; Córdoba J; Romero-Gómez M
Gastroenterology; 2015 Nov; 149(6):1483-9. PubMed ID: 26299413
[TBL] [Abstract][Full Text] [Related]
7. Animal Naming Test - a simple and accurate test for diagnosis of minimal hepatic encephalopathy and prediction of overt hepatic encephalopathy.
Agarwal A; Taneja S; Chopra M; Duseja A; Dhiman RK
Clin Exp Hepatol; 2020 Jun; 6(2):116-124. PubMed ID: 32728628
[TBL] [Abstract][Full Text] [Related]
8. Sarcopenia Is Risk Factor for Development of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt Placement.
Nardelli S; Lattanzi B; Torrisi S; Greco F; Farcomeni A; Gioia S; Merli M; Riggio O
Clin Gastroenterol Hepatol; 2017 Jun; 15(6):934-936. PubMed ID: 27816756
[TBL] [Abstract][Full Text] [Related]
9. Loss of skeletal muscle mass affects the incidence of minimal hepatic encephalopathy: a case control study.
Tateyama M; Naoe H; Tanaka M; Tanaka K; Narahara S; Tokunaga T; Kawasaki T; Yoshimaru Y; Nagaoka K; Watanabe T; Setoyama H; Sasaki Y; Tanaka Y
BMC Gastroenterol; 2020 Nov; 20(1):371. PubMed ID: 33167879
[TBL] [Abstract][Full Text] [Related]
10. [Minimal hepatic encephalopathy: a better diagnostic to improve prognostic].
Ennaifer R; Cheikh M; Hefaiedh R; Romdhane H; Ben Nejma H; Hadj NB
Presse Med; 2014 May; 43(5):e127-33. PubMed ID: 24703736
[TBL] [Abstract][Full Text] [Related]
11. Validation of the psychometric hepatic encephalopathy score (PHES) for identifying patients with minimal hepatic encephalopathy.
Duarte-Rojo A; Estradas J; Hernández-Ramos R; Ponce-de-León S; Córdoba J; Torre A
Dig Dis Sci; 2011 Oct; 56(10):3014-23. PubMed ID: 21461913
[TBL] [Abstract][Full Text] [Related]
12. Proton Pump Inhibitors Are Associated With Minimal and Overt Hepatic Encephalopathy and Increased Mortality in Patients With Cirrhosis.
Nardelli S; Gioia S; Ridola L; Farcomeni A; Merli M; Riggio O
Hepatology; 2019 Aug; 70(2):640-649. PubMed ID: 30289992
[TBL] [Abstract][Full Text] [Related]
13. Clinical Usefulness of the Inhibitory Control Test (ICT) in the Diagnosis of Minimal Hepatic Encephalopathy.
Stawicka A; Jaroszewicz J; Zbrzeźniak J; Sołowianowicz N; Woszczenko A; Świderska M; Flisiak R
Int J Environ Res Public Health; 2020 May; 17(10):. PubMed ID: 32455895
[No Abstract] [Full Text] [Related]
14. The additive value of sarcopenia, myosteatosis and hepatic encephalopathy in the predictivity of model for end-stage liver disease.
Lattanzi B; Nardelli S; Pigliacelli A; Di Cola S; Farcomeni A; D'Ambrosio D; Gioia S; Ginanni Corradini S; Lucidi C; Mennini G; Rossi M; Merli M; Riggio O
Dig Liver Dis; 2019 Nov; 51(11):1508-1512. PubMed ID: 31601536
[TBL] [Abstract][Full Text] [Related]
15. Myosteatosis and sarcopenia are associated with hepatic encephalopathy in patients with cirrhosis.
Bhanji RA; Moctezuma-Velazquez C; Duarte-Rojo A; Ebadi M; Ghosh S; Rose C; Montano-Loza AJ
Hepatol Int; 2018 Jul; 12(4):377-386. PubMed ID: 29881992
[TBL] [Abstract][Full Text] [Related]
16. Pre-transjugular intrahepatic portosystemic shunts (TIPS) prediction of post-TIPS overt hepatic encephalopathy: the critical flicker frequency is more accurate than psychometric tests.
Berlioux P; Robic MA; Poirson H; Métivier S; Otal P; Barret C; Lopez F; Péron JM; Vinel JP; Bureau C
Hepatology; 2014 Feb; 59(2):622-9. PubMed ID: 24620380
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis and Treatment of Low-Grade Hepatic Encephalopathy.
Direkze S; Jalan R
Dig Dis; 2015; 33(4):562-9. PubMed ID: 26159274
[TBL] [Abstract][Full Text] [Related]
18. Value of critical flicker frequency and psychometric hepatic encephalopathy score in diagnosis of low-grade hepatic encephalopathy.
Kircheis G; Hilger N; Häussinger D
Gastroenterology; 2014 Apr; 146(4):961-9. PubMed ID: 24365582
[TBL] [Abstract][Full Text] [Related]
19. Non invasive blood flow measurement in cerebellum detects minimal hepatic encephalopathy earlier than psychometric tests.
Felipo V; Urios A; Giménez-Garzó C; Cauli O; Andrés-Costa MJ; González O; Serra MA; Sánchez-González J; Aliaga R; Giner-Durán R; Belloch V; Montoliu C
World J Gastroenterol; 2014 Sep; 20(33):11815-25. PubMed ID: 25206287
[TBL] [Abstract][Full Text] [Related]
20. Determination of Turkish norms of psychometric tests for diagnosing minimal hepatic encephalopathy and proposal of a high sensitive screening test battery.
Özbaş B; Keskin O; Hecker H; Karahan I; Özbaş C; Kalkan Ç; Kartal A; Önder FO; Öncü BK; Gençdal G; Akyildiz M; Günşar F; Idilman R; Weissenborn K; Özütemiz Ö; Yurdaydin C
Hepatol Int; 2021 Dec; 15(6):1442-1455. PubMed ID: 34085147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
